JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Advanced pneumoconiosis among working underground coal miners--Eastern Kentucky and Southwestern Virginia, 2006.

Current regulations for U.S. underground coal mines, mandated by federal legislation in 1969 and amended in 1977, include provisions to prevent the occurrence of pneumoconiosis. However, in 2005 and 2006, clusters of rapidly progressing and potentially disabling pneumoconiosis were reported in certain geographic areas. In response to these reports, CDC's National Institute for Occupational Safety and Health (NIOSH) instituted field surveys conducted under the Enhanced Coal Workers' Health Surveillance Program (ECWHSP). This report describes the results of those surveys, which were conducted in three counties in eastern Kentucky (Knott, Letcher, and Pike) and four counties in southwestern Virginia (Buchanan, Dickenson, Tazewell, and Wise). A total of 37 cases of advanced pneumoconiosis (including four cases reported previously) were identified. Measures are needed to prevent further occurrence of this disease among underground coal miners.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app